PMID: 8584608Oct 1, 1995Paper

The effects of D1 (NNC 22-0215) and D2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeys

Psychopharmacology
D E Casey

Abstract

The effects of chronic treatment for 28 days with the oral D1 (NNC 22-0215) or D2 (haloperidol) antagonist were evaluated in nonhuman primates in a double blind, placebo controlled crossover trial. Cebus monkeys, 10-18 years old, which were previously sensitized to neuroleptics, were treated in three different groups with NNC 22-0215 2-3 mg/kg PO (n = 6), haloperidol 2-3 mg/kg PO (n = 5), or lactose placebo (n = 7) each day in a banana slice. At the end of 28 days the NNC 22-0215 group crossed over to haloperidol and the haloperidol group crossed over to NNC 22-0215 for 28 more days. The lactose group continued on lactose. Extrapyramidal symptoms (EPS) of dystonia and sedation were scored daily. Initially both NNC 22-0215 and haloperidol produced equal rates of dystonia. However, the NNC 22-0215 group demonstrated nearly full desensitization by day 2 and showed no EPS by day 6, whereas the haloperidol group had increased EPS during the first week, followed by moderate desensitization to EPS, but continued to have symptoms on each of the 28 days of treatment. At crossover, the previously treated haloperidol group rapidly desensitized with NNC 22-0215 by day 4 to show no EPS, whereas the previously treated NNC 22-0215 group showe...Continue Reading

References

Aug 14, 1992·European Journal of Pharmacology·P H AndersenE B Nielsen
Jul 20, 1991·Lancet·D E Casey
Sep 4, 1991·European Journal of Pharmacology·D McHugh, V Coffin
Jan 1, 1989·Psychopharmacology·D E Casey
Jan 1, 1988·Psychopharmacology Series·D E Casey, G A Keepers
Jul 15, 1983·European Journal of Pharmacology·J Hyttel

❮ Previous
Next ❯

Citations

Oct 1, 1995·Psychopharmacology·T R Barnes, J Gerlach
Dec 6, 2006·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Cheryl Zlotnick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.